Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
benaGene
- Development stage
- Unknown
- Lead developer
- Terra Biological
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
benaGene is an oral nutraceutical supplement developed by Terra Biological LLC, featuring a thermally-stabilized form of oxaloacetate known as Anhydrous Enol-Oxaloacetate (AEO). Formulated with Vitamin C (ascorbic acid) to ensure shelf stability, benaGene functions as a calorie restriction mimetic. It is designed to activate molecular pathways typically triggered by caloric restriction, such as the induction of Sirtuin 1 (SIRT1) and Adenosine monophosphate-activated protein kinase (AMPK), as well as the modulation of the NAD+/NADH ratio. Marketed primarily for its anti-aging properties, mitochondrial support, and cellular energy enhancement, the product is available over-the-counter and has undergone clinical evaluation for its impact on metabolic health and longevity-associated biomarkers.
- Brand names
- benaGene
- Other names
- oxaloacetateAnhydrous Enol-OxaloacetateAEO
02
Targets
AMPK (Adenosine monophosphate–activated protein kinase)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)
Beyond the preview
Go deeper on benaGene.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on benaGene.